TRANSLATIONAL PHARMACEUTICS Trademark

Trademark Overview

On Friday, November 5, 2021, a trademark application was filed for TRANSLATIONAL PHARMACEUTICS with the United States Patent and Trademark Office. The USPTO has given the TRANSLATIONAL PHARMACEUTICS trademark a serial number of 79331241. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Thursday, April 13, 2023. This trademark is owned by Quotient Sciences Ltd. The TRANSLATIONAL PHARMACEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research services relating to the pharmaceutical industry
translational pharmaceutics

General Information

Serial Number79331241
Word MarkTRANSLATIONAL PHARMACEUTICS
Filing DateFriday, November 5, 2021
Status645 - FINAL REFUSAL - MAILED
Status DateThursday, April 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch services relating to the pharmaceutical industry

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuotient Sciences Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Saturday, October 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 13, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, June 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 21, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, April 13, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 13, 2023FINAL REFUSAL E-MAILED
Thursday, April 13, 2023FINAL REFUSAL WRITTEN
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Tuesday, February 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 20, 2022REFUSAL PROCESSED BY IB
Friday, August 26, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 26, 2022REFUSAL PROCESSED BY MPU
Thursday, August 25, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 24, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 17, 2022ASSIGNED TO EXAMINER
Tuesday, January 25, 2022APPLICATION FILING RECEIPT MAILED
Friday, January 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 20, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

pharmaceutics translational industry pharmaceutical relating services research